Effect of Countermeasures on Nocturnal Driving Performance
NCT ID: NCT01070004
Last Updated: 2012-06-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
72 participants
INTERVENTIONAL
2010-01-31
2011-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Caffeine on Sleep-wake Regulation in Teenagers
NCT04321785
Development and Validation of a Driving Simulator for Evaluating the Residual Effects of Drugs on Driving Performance - Sensitivity Analysis Using Zopiclone As a Positive Control
NCT04108351
Delayed-release Bedtime Caffeine and Sleep Inertia Symptoms Immediately Upon Awakening
NCT04975360
Investigating Racing Thoughts in Patients With Insomnia Disorder
NCT04752254
Effects of Insomnia on Simulated Driving (MK-0000-183-00)
NCT01209728
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Blue light
Exposure to 460-nm monochromatic light (blue light)
Real driving situation
Continuous blue light exposure during driving compared to effects of coffee (2\*200 mg of caffeine) and coffee placebo on 4h night-time real driving situation. Inside this arm, each volunteer will be randomly allocated and will all receive : continuous blue light exposure, coffee and coffee placebo at each driving session with at least 1 week between each condition.
Physical activity
15 minutes of physical activity at a low intensity
Driving simulator
15 minutes of physical activity at a low intensity before driving compared to effects of coffee (2\*200 mg of caffeine) and coffee placebo on 4h night-time driving simulator. Inside this arm, each volunteer will be randomly allocated and will all receive : 15 minutes of physical activity, coffee and coffee placebo at each driving session with at least 1 week between each condition.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Real driving situation
Continuous blue light exposure during driving compared to effects of coffee (2\*200 mg of caffeine) and coffee placebo on 4h night-time real driving situation. Inside this arm, each volunteer will be randomly allocated and will all receive : continuous blue light exposure, coffee and coffee placebo at each driving session with at least 1 week between each condition.
Driving simulator
15 minutes of physical activity at a low intensity before driving compared to effects of coffee (2\*200 mg of caffeine) and coffee placebo on 4h night-time driving simulator. Inside this arm, each volunteer will be randomly allocated and will all receive : 15 minutes of physical activity, coffee and coffee placebo at each driving session with at least 1 week between each condition.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Presenting no disorder of the perception,
* Taking no treatment interfering with the sleep, the attentiveness and the circadian system,
* BMI ≥18 et ≤ 27
* Moderate Drinker of coffee(café) (2-3 cups a day) •
* Presenting no medical history or evolutionary pathology,
* Not presenting syndrome of apneas / hypopnea during the sleep (IAH \< 5 for 20-25 years and 10 for 40-50 years),
* Not presenting syndrome of periodic movements during the sleep (Index of MPS \< 15),
* Not professional Driver, having their driving license for at least 3 years or 2 years for the drivers who followed the learning anticipated and driving between 10000 and 20000 km a year,
* Having looked in writing their consent to participate in the study,
* Having regular schedules of life 3 days before going into the study,
* Registers on the Social Security and on the register of the healthy volunteers.
Exclusion Criteria
* Any evolutionary psychiatric affections (psychosis, disorder(confusion) of the mood or the anxiety),
* All the sleeping disorders (sleep apneas, periodic leg movements, narcolepsy, phase delay, advance of phase),
* Any evolutionary neurological affections (brain tumour, epilepsy, Headache, brain vascular accident, calcifies, myoclonia , chorea, neuropathy, muscular dystrophies, myotonic dystrophy),
* Cardiovascular Pathologies (arterial high blood pressure, cardiac insufficiency, coronary disease, vascular disorders(confusions)),
* Lung Pathologies (BPCO, BPR),
* Renal Disorders(Confusions) (renal insufficiency, nephrolithiases),
* Endocrine Pathologies (dysthyroid, diabetes),
* Drug addiction, alcoholic dependence during the last 6 months,
* Having made a trans-meridian journey (± 3 hours) in last 3 months.
20 Years
50 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ERANET
UNKNOWN
INSERM ERI27 Mobilités Cognition et Temporalité
UNKNOWN
Hotel Dieu Hospital
OTHER
IMF, CNRS UMR-5231
UNKNOWN
University Hospital, Bordeaux
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pierre Philip, Pr
Role: STUDY_DIRECTOR
University Hospital, Bordeaux
Pierre Denise, Pr
Role: PRINCIPAL_INVESTIGATOR
INSERM ERI27
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Bordeaux Groupe Hospitalier Pellegrin
Bordeaux, , France
Université de Caen Basse Normandie
Caen, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Taillard J, Capelli A, Sagaspe P, Anund A, Akerstedt T, Philip P. In-car nocturnal blue light exposure improves motorway driving: a randomized controlled trial. PLoS One. 2012;7(10):e46750. doi: 10.1371/journal.pone.0046750. Epub 2012 Oct 19.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUBX 2009/14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.